| Literature DB >> 21732249 |
Chaohong Sun1, Andrew M Petros, Philip J Hajduk.
Abstract
Fragment-based lead discovery has undergone remarkable changes over the last 15 years. During this time, the pharmaceutical industry has changed dramatically as well, and continued evolution of the industry is assured. These changes present many challenges but also several opportunities for executing fragment-based drug design. This article will explore some of the more significant changes in the industry and how they may affect future discovery efforts related to fragment-based initiatives.Mesh:
Substances:
Year: 2011 PMID: 21732249 DOI: 10.1007/s10822-011-9451-z
Source DB: PubMed Journal: J Comput Aided Mol Des ISSN: 0920-654X Impact factor: 3.686